Lee Ainslie - Maverick Capital
Holding/activity history for Vertex Pharmaceuticals (VRTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 812 | 0.01 | Reduce 44.27% | 0.01 | $406.40 |
| 2023 Q3 | 1,457 | 0.01 | Buy | 0.01 | $347.98 |
| 2021 Q4 | 0 | 0 | Sell 100.00% | 0.04 | |
| 2021 Q3 | 18,052 | 0.04 | Buy | 0.04 | $181.36 |
| 2021 Q2 | 0 | 0 | Sell 100.00% | 0.01 | |
| 2021 Q1 | 6,254 | 0.01 | Buy | 0.01 | $214.90 |
| 2020 Q2 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2020 Q1 | 460 | 0.00 | Buy | 0.00 | $236.96 |
| 2015 Q2 | 0 | 0 | Sell 100.00% | 1.00 | |
| 2015 Q1 | 524,867 | 1.00 | Buy | 1.00 | $117.97 |